Minjiang Chen
Impact in
- Cancer Research top 2%
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 77
- Cancer Immunotherapy and Biomarkers 36
- Lung Cancer Research Studies 27
- Pancreatic and Hepatic Oncology Research 11
-
- Lung Cancer Treatments and Mutations 42
- Lung Cancer Diagnosis and Treatment 23
- Ferroptosis and cancer prognosis 13
Minjiang Chen
183 papers receiving 4.0k citations
Hit Papers
Peers
Comparison fields: 5 of 127
- Cancer Research 903
- Hepatology 360
- Oncology 1.1k
- Pulmonary and Respiratory Medicine 1.2k
- Immunology 581
Countries citing papers authored by Minjiang Chen
This map shows the geographic impact of Minjiang Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minjiang Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minjiang Chen more than expected).
Fields of papers citing papers by Minjiang Chen
This network shows the impact of papers produced by Minjiang Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minjiang Chen. The network helps show where Minjiang Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Minjiang Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 7 | |
| 4 | 2024 | 7 | |
| 5 | 2024 | 10 | |
| 6 | 2023 | 15 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 3 | |
| 9 | 2022 | 4 | |
| 10 | 2021 | 15 | |
| 11 | 2021 | 9 | |
| 12 | 2021 | 11 | |
| 13 | 2021 | 97 | |
| 14 | 2019 | 42 | |
| 15 | 2018 | 204 | |
| 16 | 2017 | 12 | |
| 17 | 2017 | 31 | |
| 18 | 2016 | 7 | |
| 19 | 2014 | 48 | |
| 20 | 2012 | 0 |
About Minjiang Chen
Minjiang Chen is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Hepatology and Immunology, having authored 197 papers that have together received 4.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (42 papers), Cancer Immunotherapy and Biomarkers (36 papers), Radiomics and Machine Learning in Medical Imaging (28 papers), Lung Cancer Research Studies (27 papers), Lung Cancer Diagnosis and Treatment (23 papers), Hepatocellular Carcinoma Treatment and Prognosis (16 papers), Ferroptosis and cancer prognosis (13 papers) and Pancreatic and Hepatic Oncology Research (11 papers). The work is most often cited by research in Cancer Research (903 citations), Hepatology (360 citations), Oncology (1.1k citations), Pulmonary and Respiratory Medicine (1.2k citations) and Immunology (581 citations). Minjiang Chen has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Jiansong Ji, Qiaoyou Weng, Mengzhao Wang, Yan Xu, Jiansong Ji, Jing Zhao, Zhongwei Zhao, Shiji Fang, Wei Zhong and Gaofeng Shu. Their work appears in journals such as Oncotarget, Frontiers in Oncology, Academic Radiology, Frontiers in Immunology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.